Literature DB >> 16015488

Open radiofrequency ablation for the management of intractable epilepsy associated with sessile hypothalamic hamartoma.

Y Fujimoto1, A Kato, Y Saitoh, H Ninomiya, K Imai, N Hashimoto, H Kishima, M Maruno, T Yoshimine.   

Abstract

Sessile hypothalamic hamartoma (HH) often causes intractable epilepsy, which is difficult to control even by microsurgical resection and gamma knife surgery (GKS), especially when the hamartoma is intrahypothalamic, large, or irregularly shaped. We successfully applied radiofrequency ablation (RFA) to reduce its epileptogenicity and to disconnect seizure propagation. The patient was a 26-year-old man who presented with refractory epilepsy and severe mental retardation from age 6 months. He had undergone three surgeries yielding partial resection and conventional irradiation treatments. The residual HH was thin and shaped like a bent plate, attached widely to the floor of the third ventricle. He underwent open RFA via the transcallosal sub-choroidal approach under strict image guidance, which resulted in immediate and remarkable seizure remission without complications. This suggests that open RFA is a minimally invasive technique for an irregularly shaped HH that is difficult to treat by other modalities.

Entities:  

Mesh:

Year:  2005        PMID: 16015488     DOI: 10.1055/s-2004-830267

Source DB:  PubMed          Journal:  Minim Invasive Neurosurg        ISSN: 0946-7211


  2 in total

1.  Endoscopic surgery for hypothalamic hamartomas causing medically refractory gelastic epilepsy.

Authors:  Harold L Rekate; Iman Feiz-Erfan; Yu-Tze Ng; L Fernando Gonzalez; John F Kerrigan
Journal:  Childs Nerv Syst       Date:  2006-06-13       Impact factor: 1.475

2.  Clinical characteristics and long-term outcome of surgery for hypothalamic hamartoma in children with refractory epilepsy.

Authors:  Sita Jayalakshmi; Manas Panigrahi; Rajesh Reddy; Shanmukhi Somayajula
Journal:  Ann Indian Acad Neurol       Date:  2014-01       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.